[HTML][HTML] Antigenic evolution of SARS coronavirus 2

AZ Mykytyn, RAM Fouchier, BL Haagmans - Current Opinion in Virology, 2023 - Elsevier
SARS coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, emerged in China in
December 2019. Vaccines developed were very effective initially, however, the virus has …

Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications

S Maharjan, C Ma, B Singh, H Kang, G Orive… - Advanced Drug Delivery …, 2024 - Elsevier
Organoid cultures offer a valuable platform for studying organ-level biology, allowing for a
closer mimicry of human physiology compared to traditional two-dimensional cell culture …

Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants

C Li, J Huang, Y Yu, Z Wan, MC Chiu… - Proceedings of the …, 2023 - National Acad Sciences
The high transmissibility of SARS-CoV-2 Omicron subvariants was generally ascribed to
immune escape. It remained unclear whether the emerging variants have gradually …

Human nasal organoids model SARS-CoV-2 upper respiratory infection and recapitulate the differential infectivity of emerging variants

MC Chiu, C Li, X Liu, W Song, Z Wan, Y Yu, J Huang… - MBio, 2022 - Am Soc Microbiol
The human upper respiratory tract, specifically the nasopharyngeal epithelium, is the entry
portal and primary infection site of respiratory viruses. Productive infection of SARS-CoV-2 in …

[HTML][HTML] SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype

SB Park, M Khan, SC Chiliveri, X Hu, P Irvin… - Communications …, 2023 - nature.com
Since the emergence of the Omicron variants at the end of 2021, they quickly became the
dominant variants globally. The Omicron variants may be more easily transmitted compared …

[HTML][HTML] SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication

P Pan, W Ge, Z Lei, W Luo, Y Liu, Z Guan… - … and Targeted Therapy, 2023 - nature.com
Viral infection in respiratory tract usually leads to cell death, impairing respiratory function to
cause severe disease. However, the diversity of clinical manifestations of SARS-CoV-2 …

[HTML][HTML] Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities

J Chen, F Na - Frontiers in Bioengineering and Biotechnology, 2022 - frontiersin.org
The prevalency of lung disease has increased worldwide, especially in the aging
population. It is essential to develop novel disease models, that are superior to traditional …

[HTML][HTML] Intranasal mask for protecting the respiratory tract against viral aerosols

X Hu, S Wang, S Fu, M Qin, C Lyu, Z Ding… - Nature …, 2023 - nature.com
The spread of many infectious diseases relies on aerosol transmission to the respiratory
tract. Here we design an intranasal mask comprising a positively-charged thermosensitive …

Development trends of human organoid‐based COVID‐19 research based on bibliometric analysis

M Li, Y Yuan, T Zou, Z Hou, L Jin, B Wang - Cell Proliferation, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), a global pandemic caused by the severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has posed a catastrophic threat …

[HTML][HTML] Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and Staphylococcus aureus infections

S Liao, Y Huang, J Zhang, Q Xiong, M Chi, L Yang… - Respiratory …, 2023 - Springer
Background Early studies indicated that vitamin D (VD) exerted pleiotropic extra-skeletal
effects in the airway, but the definite linkage between VD deficiency and airway host …